Covered recipient · General Payments record
DIANE L KALLGREN
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2022
$14,937.52
- Reported across 161 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $506.85 | 30 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $138.68 | 9 |
| Amgen Inc. | $134.23 | 9 |
| LEO Pharma Inc. | $47.66 | 2 |
| GENZYME CORPORATION | $46.08 | 2 |
| Galderma Laboratories, L.P. | $37.23 | 2 |
| PFIZER INC. | $31.22 | 2 |
| Janssen Biotech, Inc. | $22.85 | 1 |
| Lilly USA, LLC | $18.35 | 1 |
| Incyte Corporation | $15.77 | 1 |
| Almirall LLC | $14.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2022 2018201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.74 | 01/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892993015 | CMS |
| ABBVIE INC. | $10.31 | 03/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892993019 | CMS |
| ABBVIE INC. | $13.69 | 03/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892993023 | CMS |
| ABBVIE INC. | $2.45 | 03/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892993027 | CMS |
| ABBVIE INC. | $19.82 | 04/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892993031 | CMS |
| ABBVIE INC. | $9.18 | 05/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892993035 | CMS |
| ABBVIE INC. | $21.30 | 06/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892993039 | CMS |
| ABBVIE INC. | $9.61 | 08/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892993043 | CMS |
| ABBVIE INC. | $26.58 | 12/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892993047 | CMS |
| Almirall LLC | $14.78 | 07/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902849563 | CMS |
| Amgen Inc. | $18.72 | 02/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939946167 | CMS |
| Amgen Inc. | $17.07 | 03/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939946173 | CMS |
| Amgen Inc. | $19.86 | 04/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939946175 | CMS |
| Amgen Inc. | $5.54 | 04/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939946169 | CMS |
| Amgen Inc. | $4.74 | 06/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939946171 | CMS |
| Amgen Inc. | $6.23 | 07/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939946177 | CMS |
| Amgen Inc. | $25.20 | 08/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939946179 | CMS |
| Amgen Inc. | $10.71 | 11/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939946181 | CMS |
| Amgen Inc. | $26.16 | 12/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939946183 | CMS |
| Galderma Laboratories, L.P. | $21.19 | 07/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952279227 | CMS |
| Galderma Laboratories, L.P. | $16.04 | 08/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952279229 | CMS |
| GENZYME CORPORATION | $23.36 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938841471 | CMS |
| GENZYME CORPORATION | $22.72 | 03/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938841491 | CMS |
| Incyte Corporation | $15.77 | 11/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 943079163 | CMS |
| Janssen Biotech, Inc. | $22.85 | 08/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 885609689 | CMS |
| LEO Pharma Inc. | $17.02 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 936234351 | CMS |
| LEO Pharma Inc. | $30.64 | 09/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 936234357 | CMS |
| Lilly USA, LLC | $18.35 | 02/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 917995879 | CMS |
| PFIZER INC. | $16.79 | 01/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949052639 | CMS |
| PFIZER INC. | $14.43 | 11/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949622725 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.